Page 111 - Cigna News Today

The so-called PBMs have long clawed back a fee from pharmacies weeks or months after they dispense a drug.

(Bloomberg) -- Cracks in the retail and property empire of Austrian billionaire Rene Benko are widening two weeks after the firm revealed its cash reserves were drying up. Most Read from BloombergHamas Chief Who Deceived Israel Is Target No. 1 Deep UndergroundBiden, Xi Declare Progress After Concluding Four-Hour Summit‘Fed-Friendly’ Data Lift Bonds as Stocks Struggle: Markets WrapXi Says China Seeks to Be Friends With US, Won’t Fight ‘Hot War’Some holders of Si...

A federal appeals court has rejected a bid to toss a special master from opioid litigation because of a mistaken “reply all” email that included his private notes.

Ushur Achieves ISO 27001 Certification for Its AI-Powered Customer Experience Automation Platform

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, or PBMs, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.

Plus TechFW seeks inaugural CEO and Medical City Plano's maternal and neonatal designation.

The Biden administration's first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry's price negotiators is backfiring, pharmacists say.

Reforming the current PBM market is a pro growth reform because government policies have misaligned market incentives which imposes excessive costs on patients.

Healthcare